Femhrt Articles
New Warner Chilcott posts 1st-qtr loss
11 July 2005
Warner Chilcott's low-dose femhrt approved
24 January 2005
UPDATE: Ireland's Warner Chillcott mulls L1.7 billion offer from private equity group
27 September 2004
Warner Chilcott beats expectations
16 August 2004
Galen sees 2nd-qtr 2004 EPS rocket 84%
24 May 2004
Galen reports 105% leap in 1st-qtr sales
16 February 2004
Barr Labs and Galen in oral contraceptives licensing deal
22 September 2003
Stock Commentary - Europe
18 August 2003
Galen completes Pfizer product acquisitions
28 April 2003
Galen seeking to buy Pfizer drugs for $359M
10 March 2003
Warner-Lambert's Lipitor And Rezulin Will Fuel Growth
9 September 1998
W-L To Stay Independent As Product Line Improves
30 April 1998
W-L To Stay Independent As Product Line Improves
24 April 1998
Showing 1-16 of 16 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
